Ken Bartizal

Affiliations

  • Chief Development Officer at Cidara Therapeutics Inc. (CDTX), 2017-04-04
  • Chief Development Officer at Trius Therapeutics Inc (TSRX), 2013-09-13
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TSRX $8.14 2,000 $16,280.00 95,300 2013-07-01 Filing
TSRX $7.90 2,000 $15,800.00 97,300 2013-06-04 Filing
TSRX $7.93 12,000 $95,119.20 98,927 2013-05-24 Filing
TSRX $7.85 12,000 $94,200.00 110,927 2013-05-14 Filing
TSRX $7.85 12,000 $94,200.00 98,927 2013-05-14 Filing